Online citations, reference lists, and bibliographies.
← Back to Search

Differential MicroRNA Expression Profiling Of Mesothelioma And Expression Analysis Of MiR-1 And MiR-214 In Mesothelioma.

V. Amatya, A. S. Mawas, K. Kushitani, Mouchira M Mohi El-Din, Y. Takeshima
Published 2016 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant mesothelioma is a highly aggressive cancer with poor prognosis and refractory to currently available therapies. Most of the patients with advanced invasive nature are not amenable to surgical resection and/or available anticancer therapy, thus development of novel effective therapeutic regimes is needed. Aberrant expression of microRNAs (miRNAs) has been proposed to contribute to carcinogenesis and aggressiveness of mesothelioma. We analyzed miRNA expression in mesothelioma cell lines using TaqMan miRNA expression array and found significant number of miRNAs, which showed increased or lost expression. We validated the increased expression of miR-182, and miR-183 in mesothelioma cell lines by individual miRNA assays and SmartFlare miRNA probes. We further investigated the miR-1, and miR-214, which were not expressed in mesothelioma cells by real-time RT-PCR. Transfection of mesothelioma cells, ACC-Meso-1 and CRL5915, with miRNA mimic (hsa-miR-1 mimic and hsa-miR-214 mimic) led to inhibition of cell growth, invasion and migration. We paid attention to PIM1, the target gene of both miR-1 and miR-214 miRNAs and which was found overexpressed in mesothelioma cells, and miR-1 and miR-214 mimic transfection of mesothelioma cell lines showed downregulation of PIM1 by western blot analysis. The miRNAs, miR-1 and miR-214, may play a role in carcinogenesis of mesothelioma thus might be considered as candidate therapeutic targets in mesothelioma.
This paper references
10.1158/1078-0432.CCR-10-3040
Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma
T. Kubo (2011)
10.1016/j.ejca.2011.06.030
The functional significance of miR-1 and miR-133a in renal cell carcinoma.
K. Kawakami (2012)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
10.3892/or.2011.1449
Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.
V. Amatya (2011)
Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer.
U. Warnecke-Eberz (2009)
10.3892/OR_00000050
Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
U. Warnecke-Eberz (2008)
10.1371/journal.pone.0080609
The miR-1-NOTCH3-Asef Pathway Is Important for Colorectal Tumor Cell Migration
S. Furukawa (2013)
10.1165/rcmb.2009-0060OC
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Sara Busacca (2010)
10.2144/000113083
TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays.
Tobias Gebäck (2009)
10.1038/NRG1379
MicroRNAs: small RNAs with a big role in gene regulation
L. He (2004)
10.1371/journal.pone.0118086
MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer
J. Wang (2015)
10.1016/j.lungcan.2009.01.011
Accuracy of pathological diagnosis of mesothelioma cases in Japan: clinicopathological analysis of 382 cases.
Y. Takeshima (2009)
10.2174/138920209787581299
MicroRNA Gene Networks in Oncogenesis
A. Drakaki (2009)
10.1007/s13277-015-3358-6
MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET
C. Han (2015)
10.1038/35090585
Delineation of prognostic biomarkers in prostate cancer
S. Dhanasekaran (2001)
10.3892/or.2012.2116
CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
V. Amatya (2013)
10.2144/000112257
CellProfiler: free, versatile software for automated biological image analysis.
Michael R Lamprecht (2007)
10.18632/oncotarget.5478
microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)
H. Long (2015)
Overexpression of miR - 2143 p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG - BP 1
H Tsukiji (2015)
10.1186/s13045-014-0095-z
Pim kinases in hematological malignancies: where are we now and where are we going?
P. Mondello (2014)
10.1093/nar/gkt1266
miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions
S. Hsu (2014)
10.1158/0008-5472.CAN-09-3993
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
H. Pass (2010)
10.1111/jgh.13180
The tumor‐suppressive function of miR‐1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma
Yan-yan Du (2016)
10.1016/j.febslet.2013.01.016
MiR‐214 reduces cell survival and enhances cisplatin‐induced cytotoxicity via down‐regulation of Bcl2l2 in cervical cancer cells
F. Wang (2013)
10.1111/j.1742-4658.2012.08618.x
Down‐regulation of miR‐214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist
B. Li (2012)
10.1136/oem.2003.010165
Changing trends in US mesothelioma incidence
H. Weill (2004)
10.1111/j.1349-7006.2006.00184.x
Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients
N. Usami (2006)
10.1371/journal.pone.0044206
MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma
Hongping Xia (2012)
10.1111/j.1365-2559.2010.03549.x
Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non‐neoplastic mesothelial cells
Hiromi Tsukiji (2010)
10.4161/cbt.7.9.6418
Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
C. Reiser-Erkan (2008)
10.1007/s00018-014-1584-5
Role of microRNAs in malignant mesothelioma
A. Truini (2014)
10.1097/JTO.0b013e3181f1cf2b
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1097/JTO.0b013e3182572e83
Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
M. Kirschner (2012)
10.1016/0011-3840(93)90029-G
Malignant pleural mesothelioma.
H. Pass (2004)
10.1002/ijc.25285
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
G. V. Gee (2010)
10.1371/journal.pone.0018232
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
L. Santarelli (2011)
10.1074/jbc.W118.004967
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
M. Nasser (2018)
10.1038/onc.2015.271
Overexpression of miR-214-3p in Esophageal Squamous Cancer Cells Enhances Sensitivity to Cisplatin by Targeting Survivin Directly and Indirectly Through CUG-BP1
P. Phatak (2016)
10.1593/NEO.81038
Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor.
K. Peltola (2009)
Malignant mesothelioma mortality--United States, 1999-2005.
K. M. Bang (2009)
10.1371/journal.pone.0076994
MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214
A. Srivastava (2013)
10.1378/chest.12-2770
miR-1 induces growth arrest and apoptosis in malignant mesothelioma.
Y. Xu (2013)
10.1371/journal.pone.0098675
miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer
O. Karatas (2014)



This paper is referenced by
10.1016/j.biopha.2020.110903
miR-1: A comprehensive review of its role in normal development and diverse disorders.
Amin Safa (2020)
10.18632/oncotarget.20409
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
Kimberly A. Birnie (2017)
10.18632/oncotarget.18648
Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells.
Shih-Ming Chen (2017)
10.1016/j.biopha.2017.07.075
Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma.
Md. Abu Sayeed (2017)
Repression of the protein kinase PIM3 by an mTORC1-regulated microRNA
Ilana Kelsey (2017)
10.1016/j.bbagrm.2016.12.004
Regulation of microRNA-1 (miR-1) expression in human cancer.
C. Han (2017)
10.1002/1878-0261.12150
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma
K. Schelch (2018)
10.1038/s41598-017-14864-1
Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214
Po-Shuan Huang (2017)
10.3389/fonc.2020.00105
Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
G. Reid (2020)
10.1146/annurev-physiol-021115-105211
The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology.
H. Yu (2017)
10.1177/1758835920971421
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
H. Yang (2020)
10.3389/fonc.2018.00650
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
G. Lo Russo (2018)
10.1016/j.jri.2020.103184
Interplay of microRNAs to genetic, epigenetic, copy number variations of cervical cancer related genes.
Jingfang Dai (2020)
10.1002/1878-0261.12386
Post‐transcriptional regulation of PIAS3 expression by miR‐18a in malignant mesothelioma
T. He (2018)
10.1038/s41598-017-11067-6
SmartFlares fail to reflect their target transcripts levels
Maria Czarnek (2017)
10.1016/j.biocel.2017.10.016
PIM kinases: From survival factors to regulators of cell motility.
Niina M. Santio (2017)
10.3389/fonc.2018.00446
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
Rui Suzuki (2018)
10.1080/14737159.2018.1440208
Localized surface plasmon resonance based biosensing
A. Csaki (2018)
10.3892/ijo.2017.3863
PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.
A. S. Mawas (2017)
10.1016/j.ncrna.2018.08.001
Relations between approved platinum drugs and non-coding RNAs in mesothelioma
B. Biersack (2018)
10.1002/adma.201901743
Nucleic-Acid Structures as Intracellular Probes for Live Cells.
Devleena Samanta (2019)
Semantic Scholar Logo Some data provided by SemanticScholar